These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 12642477)
1. Pharmacokinetics and metabolism of a COX-2 inhibitor, valdecoxib, in mice. Zhang JY; Yuan JJ; Wang YF; Bible RH; Breau AP Drug Metab Dispos; 2003 Apr; 31(4):491-501. PubMed ID: 12642477 [TBL] [Abstract][Full Text] [Related]
2. Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in human. Yuan JJ; Yang DC; Zhang JY; Bible R; Karim A; Findlay JW Drug Metab Dispos; 2002 Sep; 30(9):1013-21. PubMed ID: 12167567 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC-MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice. Jin X; Zhou F; Liu Y; Cheng C; Yao L; Jia Y; Wang G; Zhang J J Pharm Biomed Anal; 2018 Sep; 158():1-7. PubMed ID: 29843006 [TBL] [Abstract][Full Text] [Related]
4. The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor. Sarapa N; Britto MR; Mainka MB; Parivar K Eur J Clin Pharmacol; 2005 Jun; 61(4):247-56. PubMed ID: 15887009 [TBL] [Abstract][Full Text] [Related]
5. Biotransformation of valdecoxib by microbial cultures. Keshetti S; Ciddi V J Microbiol Biotechnol; 2010 Apr; 20(4):809-16. PubMed ID: 20467258 [TBL] [Abstract][Full Text] [Related]
6. Effects of Dexmedetomidine on the Pharmacokinetics of Parecoxib and Its Metabolite Valdecoxib in Beagles by UPLC-MS/MS. Hu J; Lv BF; Guo WJ; Wang BW; Miao D; Qiu XJ; Chen XP Biomed Res Int; 2020; 2020():1563874. PubMed ID: 32832543 [TBL] [Abstract][Full Text] [Related]
7. Reductive isoxazole ring opening of the anticoagulant razaxaban is the major metabolic clearance pathway in rats and dogs. Zhang D; Raghavan N; Chen SY; Zhang H; Quan M; Lecureux L; Patrone LM; Lam PY; Bonacorsi SJ; Knabb RM; Skiles GL; He K Drug Metab Dispos; 2008 Feb; 36(2):303-15. PubMed ID: 17984286 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous Determination of Parecoxib and Its Metabolite Valdecoxib Concentrations in Beagle Plasma by UPLC-MS/MS and Application for Pharmacokinetics Study. Li SL; Zhu YL; Zhu CY; Li SB; Li ZH; Qiu XJ Drug Des Devel Ther; 2020; 14():1117-1125. PubMed ID: 32214797 [TBL] [Abstract][Full Text] [Related]
9. Development of a population pharmacokinetic model for parecoxib and its active metabolite valdecoxib after parenteral parecoxib administration in children. Hullett B; Salman S; O'Halloran SJ; Peirce D; Davies K; Ilett KF Anesthesiology; 2012 May; 116(5):1124-33. PubMed ID: 22450476 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics and in vitro/ex vivo cyclooxygenase selectivity of parecoxib and its active metabolite valdecoxib in cats. Kim TW; Vercelli C; Briganti A; Re G; Giorgi M Vet J; 2014 Oct; 202(1):37-42. PubMed ID: 25135338 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection. Pavan Kumar VV; Vinu MC; Ramani AV; Mullangi R; Srinivas NR Biomed Chromatogr; 2006 Jan; 20(1):125-32. PubMed ID: 16013036 [TBL] [Abstract][Full Text] [Related]
12. A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma. Werner U; Werner D; Hinz B; Lambrecht C; Brune K Biomed Chromatogr; 2005 Mar; 19(2):113-8. PubMed ID: 15473012 [TBL] [Abstract][Full Text] [Related]
13. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats. Johnson KA; Prakash C Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349 [TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects. Karim A; Laurent A; Slater ME; Kuss ME; Qian J; Crosby-Sessoms SL; Hubbard RC J Clin Pharmacol; 2001 Oct; 41(10):1111-9. PubMed ID: 11583480 [TBL] [Abstract][Full Text] [Related]
15. Collision-induced dissociation of valdecoxib metabolites: a novel rearrangement involving an isoxazole ring. Zhang JY; Xu F; Breau AP J Mass Spectrom; 2004 Mar; 39(3):295-302. PubMed ID: 15039937 [TBL] [Abstract][Full Text] [Related]
16. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study. Tiseo PJ; Perdomo CA; Friedhoff LT Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):19-24. PubMed ID: 9839761 [TBL] [Abstract][Full Text] [Related]
17. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers. Paulson SK; Hribar JD; Liu NW; Hajdu E; Bible RH; Piergies A; Karim A Drug Metab Dispos; 2000 Mar; 28(3):308-14. PubMed ID: 10681375 [TBL] [Abstract][Full Text] [Related]
18. Determination of valdecoxib in serum using a HPLC-diode array detector and its application in a pharmacokinetic study. Keshetty S; Venisetty RK; Molmoori V; Ciddi V Pharmazie; 2006 Mar; 61(3):245-6. PubMed ID: 16599270 [TBL] [Abstract][Full Text] [Related]
19. Pre-clinical assessment of DRF 4367, a novel COX-2 inhibitor: evaluation of pharmacokinetics, absolute oral bioavailability and metabolism in mice and comparative inter-species in vitro metabolism. Bhamidipati R; Mujeeb S; Dravid PV; Khan AA; Singh SK; Rao YK; Mullangi R; Srinivas NR Xenobiotica; 2005 Mar; 35(3):253-71. PubMed ID: 16019950 [TBL] [Abstract][Full Text] [Related]
20. An effective dose of valdecoxib in experimental mouse models of pain. Guo CX; Irwin MG; Cheung KM; Chan D Methods Find Exp Clin Pharmacol; 2007; 29(6):383-8. PubMed ID: 17922065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]